Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer
Yamada, Y., Higuchi, K., Nishikawa, K., Gotoh, M., Fuse, N., Sugimoto, N., Nishina, T., Amagai, K., Chin, K., Niwa, Y., Tsuji, A., Imamura, H., Tsuda, M., Yasui, H., Fujii, H., Yamaguchi, K., Yasui, H., Hironaka, S., Shimada, K., Miwa, H., Hamada, C., Hyodo, I.
Published in Annals of oncology (01.01.2015)
Published in Annals of oncology (01.01.2015)
Get full text
Journal Article
Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G)
Yamazaki, K., Nagase, M., Tamagawa, H., Ueda, S., Tamura, T., Murata, K., Eguchi Nakajima, T., Baba, E., Tsuda, M., Moriwaki, T., Esaki, T., Tsuji, Y., Muro, K., Taira, K., Denda, T., Funai, S., Shinozaki, K., Yamashita, H., Sugimoto, N., Okuno, T., Nishina, T., Umeki, M., Kurimoto, T., Takayama, T., Tsuji, A., Yoshida, M., Hosokawa, A., Shibata, Y., Suyama, K., Okabe, M., Suzuki, K., Seki, N., Kawakami, K., Sato, M., Fujikawa, K., Hirashima, T., Shimura, T., Taku, K., Otsuji, T., Tamura, F., Shinozaki, E., Nakashima, K., Hara, H., Tsushima, T., Ando, M., Morita, S., Boku, N., Hyodo, I.
Published in Annals of oncology (01.08.2016)
Published in Annals of oncology (01.08.2016)
Get full text
Journal Article
Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials
Yoshino, T., Cleary, J.M., Van Cutsem, E., Mayer, R.J., Ohtsu, A., Shinozaki, E., Falcone, A., Yamazaki, K., Nishina, T., Garcia-Carbonero, R., Komatsu, Y., Baba, H., Argilés, G., Tsuji, A., Sobrero, A., Yamaguchi, K., Peeters, M., Muro, K., Zaniboni, A., Sugimoto, N., Shimada, Y., Tsuji, Y., Hochster, H.S., Moriwaki, T., Tran, B., Esaki, T., Hamada, C., Tanase, T., Benedetti, F., Makris, L., Yamashita, F., Lenz, H.-J.
Published in Annals of oncology (01.01.2020)
Published in Annals of oncology (01.01.2020)
Get full text
Journal Article
The effect of CYP2C19 polymorphism on the safety, tolerability, and pharmacokinetics of tivantinib (ARQ 197): results from a phase I trial in advanced solid tumors
Yamamoto, N., Murakami, H., Nishina, T., Hirashima, T., Sugio, K., Muro, K., Takahashi, T., Naito, T., Yasui, H., Akinaga, S., Koh, Y., Boku, N.
Published in Annals of oncology (01.06.2013)
Published in Annals of oncology (01.06.2013)
Get full text
Journal Article
Multicenter phase I/II study of nivolumab combined with paclitaxel plus ramucirumab as the second-line treatment in patients with advanced gastric cancer
Kadowaki, S., Izawa, N., Minashi, K., Nishina, T., Yamanaka, T., Muro, K., Sunakawa, Y., Hironaka, S., Kajiwara, T., Kawakami, Y., Nakajima, T.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
SUNRISE-DI study: decision impact of the 12-gene recurrence score (12-RS) assay on adjuvant chemotherapy recommendation for stage II and IIIA/B colon cancer
Watanabe, J., Sato, T., Kagawa, Y., Oki, E., Kuboki, Y., Ikeda, M., Ueno, H., Kato, T., Kusumoto, T., Masuishi, T., Yamaguchi, K., Kanazawa, A., Nishina, T., Uetake, H., Yamanaka, T., Yoshino, T.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
Avelumab (anti–PD-L1) in Japanese patients with advanced gastric or gastroesophageal junction cancer (GC/GEJC): Updated results from the phase Ib JAVELIN solid tumour JPN trial
Doi, T., Iwasa, S., Muro, K., Satoh, T., Hironaka, S., Esaki, T., Nishina, T., Hara, H., Machida, N., Komatsu, Y., Shimada, Y., Otsu, S., Shimizu, S., Chand, V., Watanabe, M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Impact of excision repair cross-complementing gene 1 (ERCC1) on the outcomes of patients with advanced gastric cancer: correlative study in Japan Clinical Oncology Group Trial JCOG9912
Yamada, Y., Boku, N., Nishina, T., Yamaguchi, K., Denda, T., Tsuji, A., Hamamoto, Y., Konishi, K., Tsuji, Y., Amagai, K., Ohkawa, S., Fujita, Y., Nishisaki, H., Kawai, H., Takashima, A., Mizusawa, J., Nakamura, K., Ohtsu, A.
Published in Annals of oncology (01.10.2013)
Published in Annals of oncology (01.10.2013)
Get full text
Journal Article
A phase II study of trastuzumab with S-1 plus oxaliplatin for HER2-positive advanced gastric cancer (HIGHSOX)
Chin, K., Takashima, A., Minashi, K., Kadowaki, S., Nishina, T., Nakajima, T.E., Amagai, K., Machida, N., Gotoh, M., Taku, K., Ishizuka, N., Takahari, D.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer
Matsubara, J, Nishina, T, Yamada, Y, Moriwaki, T, Shimoda, T, Kajiwara, T, Nakajima, T E, Kato, K, Hamaguchi, T, Shimada, Y, Okayama, Y, Oka, T, Shirao, K
Published in British journal of cancer (26.02.2008)
Published in British journal of cancer (26.02.2008)
Get full text
Journal Article
A multicentre, prospective clinical evaluation study for analyzing RAS mutational status utilizing plasma circulating tumor DNA in patients with metastatic colorectal cancer
Kagawa, Y., Kato, T., Bando, H., Akagi, K., Denda, T., Nishina, T., Komatsu, Y., Oki, E., Kudo, T., Yamanaka, T., Yoshino, T.
Published in Annals of oncology (01.06.2018)
Published in Annals of oncology (01.06.2018)
Get full text
Journal Article
Chemotherapy after nivolumab for advanced gastric cancer (REVIVE): a prospective observational study
Narita, Y, Matsushima, T, Sakamoto, Y, Matsuoka, H, Tanioka, H, Kawakami, T, Shoji, H, Mizukami, T, Izawa, N, Nishina, T, Yamamoto, Y, Mitani, S, Nakamura, M, Misumi, T, Muro, K
Published in ESMO open (01.12.2023)
Published in ESMO open (01.12.2023)
Get full text
Journal Article
Impact of the 12-gene recurrence score assay on deciding adjuvant chemotherapy for stage II and IIIA/B colon cancer: the SUNRISE-DI study
Oki, E., Watanabe, J., Sato, T., Kagawa, Y., Kuboki, Y., Ikeda, M., Ueno, H., Kato, T., Kusumoto, T., Masuishi, T., Yamaguchi, K., Kanazawa, A., Nishina, T., Uetake, H., Yamanaka, T., Yoshino, T.
Published in ESMO open (01.06.2021)
Published in ESMO open (01.06.2021)
Get full text
Journal Article
BIG BANG study: A multicenter phase II study of the MEK inhibitor binimetinib + BRAF inhibitor encorafenib + anti-EGFR antibody cetuximab in patients with BRAF non-V600E mutated metastatic colorectal cancer (EPOC 1703)
Kotani, D., Bando, H., Masuishi, T., Komatsu, Y., Yamaguchi, K., Nakajima, T.E., Satoh, T., Nishina, T., Esaki, T., Nomura, S., Sakamoto, S., Iida, S., Matsuda, S., Yonemura, M., Fuse, N., Sato, A., Fujii, S., Ebi, H., Ohtsu, A., Yoshino, T.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer
Koizumi, W, Yamaguchi, K, Hosaka, H, Takinishi, Y, Nakayama, N, Hara, T, Muro, K, Baba, H, Sasaki, Y, Nishina, T, Fuse, N, Esaki, T, Takagi, M, Gotoh, M, Sasaki, T
Published in British journal of cancer (15.10.2013)
Published in British journal of cancer (15.10.2013)
Get full text
Journal Article
BRAVERY study: A multicenter phase II study of eribulin in patients with BRAF V600E mutant metastatic colorectal cancer (EPOC1701)
Masuishi, T., Taniguchi, H., Kotani, D., Bando, H., Komatsu, Y., Yamaguchi, K., Nakajima, T.E., Satoh, T., Nishina, T., Esaki, T., Wakabayashi, M., Nomura, S., Sakamoto, S., Ono, H., Hirano, N., Fujishiro, N., Fuse, N., Sato, A., Ohtsu, A., Yoshino, T.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Association of PD-L1 and PD-L2 expression and tumor-infiltrating lymphocytes in BRAF V600E-mutated metastatic colorectal cancer: GI-SCREEN post-hoc analysis
M. Imai, Y. Nakamura, T. Denda, Y. Komatsu, S. Yuki, T. Nishina, Y. Hamamoto, H. Hara, T. Esaki, H. Kawakami, K. Kato, T. Satoh, N. Okano, Y. Sunakawa, H. Taniguchi, K. Yamaguchi, T. Yamada, I. Miki, M. Wakabayashi, T. Kuwata, K. Shitara, T. Yoshino
Published in ESMO Gastrointestinal Oncology (01.12.2023)
Published in ESMO Gastrointestinal Oncology (01.12.2023)
Get full text
Journal Article
A phase II study to explore biomarkers for the use of mFOLFOX6/XELOX plus bevacizumab as a first-line chemotherapy in patients with metastatic colorectal cancer (WJOG7612GTR)
Okamoto, W., Sakai, K., Makiyama, A., Yamamoto, Y., Shitara, K., Denda, T., Izawa, N., Nakano, Y., Nishina, T., Esaki, T., Hara, H., Miura, Y., Boku, N., Yamazaki, K., Hironaka, S., Misumi, T., Hyodo, I., Muro, K., Nishio, K.
Published in ESMO open (01.12.2022)
Published in ESMO open (01.12.2022)
Get full text
Journal Article